- Home
- MLYS vs NSIT Comparison
MLYS vs NSIT Comparison
Compare MLYS & NSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLYS | NSIT |
|---|---|---|
| Founded | 2019 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 2023 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MLYS | NSIT |
|---|---|---|
| Price | $38.73 | $85.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | $46.40 | ★ $128.33 |
| AVG Volume (30 Days) | ★ 1.9M | 439.4K |
| Earning Date | 11-10-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.21 |
| Revenue | N/A | ★ $8,271,548,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.57 |
| P/E Ratio | ★ N/A | $20.43 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.24 | $81.59 |
| 52 Week High | $47.65 | $181.92 |
Technical Indicators
Market Signals| Indicator | MLYS | NSIT |
|---|---|---|
| Relative Strength Index (RSI) | 42.94 | 34.42 |
| Support Level | $41.50 | $85.10 |
| Resistance Level | $44.13 | $90.38 |
| Average True Range (ATR) | 2.37 | 2.81 |
| MACD | -0.63 | 0.91 |
| Stochastic Oscillator | 15.49 | 42.78 |
Price Performance
Historical ComparisonAbout MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.